Efficacy and Safety of Dulaglutide Biosimilar LY05008 Versus the Reference Product Dulaglutide (Trulicity) in Chinese Adults With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Active Comparator Study [0.03%]
LY05008（ dulaglutide仿制药）与对照药 trulicity（ dulaglutide）在中国2型糖尿病成人患者中的疗效和安全性：一项随机、开放标签、阳性对照研究
Li Liu,Zhifeng Cheng,Lianwei Wang et al.
Li Liu et al.
Background: Dulaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been approved for improving glycemic control and reducing the risk of cardiovascular (CV) adverse events. A previous result in healthy Chine...
Clinical Trial
Journal of diabetes. 2025 Apr;17(4):e70077. DOI:10.1111/1753-0407.70077 2025
Efficacy of GLP-1 Receptor Agonist-Based Therapies on Cardiovascular Events and Cardiometabolic Parameters in Obese Individuals Without Diabetes: A Meta-Analysis of Randomized Controlled Trials [0.03%]
GLP-1受体激动剂治疗对无糖尿病肥胖者的心血管事件和心代谢指标的影响：随机对照试验的meta分析研究
Yue Yin,Minghan Zhang,Qiuyu Cao et al.
Yue Yin et al.
Background: The cardioprotective effects of glucagon-like peptide-1 receptor agonist (GLP-1RA)-based therapies in nondiabetic individuals with overweight or obesity remain underexplored. This meta-analysis evaluates their...
Meta-Analysis
Journal of diabetes. 2025 Apr;17(4):e70082. DOI:10.1111/1753-0407.70082 2025
Gut Microbiota and Their Metabolites: The Hidden Driver of Diabetic Nephropathy? Unveiling Gut Microbe's Role in DN [0.03%]
肠道菌群及其代谢产物：糖尿病肾病的幕后推手？揭秘肠道菌群在DN中的作用
Jinzhou Liu,Min Guo,Xiaobin Yuan et al.
Jinzhou Liu et al.
Background: Diabetic nephropathy (DN) is a severe microvascular complication of diabetes with a complex pathogenesis. Methods: Recent s...
Socioeconomic Status, Modifiable Factors, and Risk of Microvascular Complications in Individuals With Type 2 Diabetes: A Cohort Study From the UK Biobank [0.03%]
基于英国生物银行队列探讨2型糖尿病患者的社会经济地位、可改变因素与微血管并发症风险之间的关系研究
Ying Li,Qiqi You,Menglin Fan et al.
Ying Li et al.
Background: To investigate whether lower socioeconomic status (SES) was associated with an increased risk of diabetic microvascular complications and to analyze the potential mediating role of several modifiable factors. ...
Comparative Analysis of Type 2 Diabetes Prevalence and Clinical Profiles in Ethiopia and Nigeria [0.03%]
埃塞俄比亚和尼日利亚2型糖尿病患病率及临床特征的比较分析
Assefa Mulu Baye,Teferi Gedif Fenta,Suvi Karuranga et al.
Assefa Mulu Baye et al.
Aims: We aimed to determine the prevalence of diabetes and the clinical profiles of Type 2 diabetes in Ethiopia and Nigeria. Methods: A...
Comparative Study
Journal of diabetes. 2025 Apr;17(4):e70078. DOI:10.1111/1753-0407.70078 2025
Muscle Strength, Genetic Risk, and Type 2 Diabetes Among Individuals of South Asian Ancestry: A UK Biobank Study [0.03%]
肌肉力量、遗传风险和南亚裔人群的二型糖尿病：一项英国生物样本库研究
Ziyuan Chen,Paul James Collings,Mengyao Wang et al.
Ziyuan Chen et al.
Objective: To examine the independent and combined associations of genetic risk and muscle strength with the risk of incident type 2 diabetes (T2D) and glycated hemoglobin (HbA1c) among individuals of South Asian ancestry...
Prevalence and Clinical Characteristics of NEUROD1-MODY in Chinese Early-Onset Type 2 Diabetes Mellitus and a Literature Review [0.03%]
中国早发2型糖尿病中NEUROD1-MODY的流行病学和临床特征及文献复习
Tianhao Ba,Qian Ren,Siqian Gong et al.
Tianhao Ba et al.
Background: Maturity-onset diabetes of the young resulting from mutations of the NEUROD1 gene (NEUROD1-MODY) is a rare form of diabetes and has not been well studied. We aimed to estimate its prevalence in Chinese patient...
Diabetes Complications and Comorbidities as Risk Factors for MACE in People With Type 2 Diabetes and Their Development Over Time: A Danish Registry-Based Case-Control Study [0.03%]
2型糖尿病患者心血管不良事件的风险因素：丹麦一项基于登记表的病例对照研究中的糖尿病并发症和合并症及其随时间的发展变化
Asger Ahlmann Bech,Mia Daugaard Madsen,Annika Vestergaard Kvist et al.
Asger Ahlmann Bech et al.
Aim: This study aimed to investigate the association between cardiovascular risk factors and major adverse cardiovascular events (MACE) in people with type 2 diabetes, while assessing potential changes over time. ...
The Relationship Between Glycated Albumin and Time in Tight Range in Type 2 Diabetes [0.03%]
糖化白蛋白与2型糖尿病血糖在目标范围内时间的关系
Jiaying Ni,Wenshuo Han,Yaxin Wang et al.
Jiaying Ni et al.
Aims: Among the new glucose metrics derived from continuous glucose monitoring, the concept of time in tight range (TITR) has gained increasing attention. We aimed to assess the association between TITR and traditional gl...